Sudden death from cardiac causes remains a leading cause of death among patients with congestive heart failure (CHF). Treatment with amiodarone or an implantable cardioverter–defibrillator (ICD ...

The extravascular implantable cardioverter–defibrillator (ICD) has a single lead implanted substernally to enable pause-prevention pacing, antitachycardia pacing, and defibrillation energy ...

The implantable cardioverter-defibrillator (ICD) has been shown to decrease the risk of sudden cardiac death in patients when used for primary and secondary prevention. These devices are being ...

Targeted ICD selection based on predicted therapy benefit enhances patient outcomes while cutting hospital costs by 16.7%.

New York, Sept. 27, 2023 (GLOBE NEWSWIRE) -- According to a recent report by Market.us, the Global Implantable Cardioverter Defibrillator Market size is expected to be worth around USD 7.7 Billion ...

Surge in contributing factors such as obesity and sedentary lifestyle is a key factor driving revenue growth of the global implantable cardioverter defibrillator market to a significant ...

Drs. Schoenfeld and Reynolds trace the history of remote monitoring of ICDs and reflect on its current status and future role in clinical practice.

Cite this: Complications of Implantable Cardioverter Defibrillator Therapy in 440 Consecutive Patients - Medscape - Sep 01, 2005. Abstract and Introduction Methods ...

New research from the University of Minnesota Medical School demonstrates that using cardiovascular magnetic resonance imaging—known as CMR phenotyping—can help identify patients with suspected ...